Keeping a symptom diary helps distinguish between IBS flares and medication side effects, guiding appropriate management adjustments
From early peptide synthesis to uncovering GLP-1s incretin role, her impactful studies bridge fundamental science and clinical medicine
Tirzepatide, as a dual GIP/GLP-1 receptor agonist, shows no increased UTI risk in clinical trials
Dose and treatment duration: Higher doses and longer treatment periods might increase the risk of muscle loss
Through our telehealth platform, you can access personalized treatment programs that include either oral or injectable options
A history of pancreatitis Gallbladder problems Kidney disease Personal or family history of medullary thyroid carcinoma (MTC) (thyroid tumors) Multiple endocrine neoplasia syndrome type 2 (MEN2) Diabetic retinopathy High triglyceride levels Any digestive disorders Additionally, pregnant women, women who are trying to conceive, or women who are breastfeeding may not be prescribed semaglutide